Inner Banner

International 2025

breadCrumb

Submitted by admin on Tue, 11/26/2024 - 17:11
Type
common
  1. Adhvaryu VV, Gurav M, Deshpande G, Rumde R, Shetty O, Sahay A, Sahu A, Dasgupta A, Chatterji A, Gupta T, Shetty P, Moiyadi A, Epari S (2025). Adult medulloblastoma: Clinicomolecular spectrum, an institutional experience. International Journal of Surgical Pathology.

  2. Ambulkar R, Kunte A, Solanki SL, Thakkar V, Deshmukh B, Rana PS (2025). Impact of Prehabilitation in Major Gastrointestinal Oncological Surgery: a Systematic Review. Journal of Gastrointestinal Cancer 56(1):133. PMID: 40500487

  3. Agrawal N, Govekar R (2025). Incremental modification in the existing approaches for affinity chromatographic enrichment of phosphoproteins improves their profile in liquid chromatography-tandem mass spectrometry analysis. Analytical Science Advances. 6(1):e202400058.

  4. Anthony C, Harish M, Christie J, Venkatraman P (2025). Novel interaction with PSMD9 regulates DNAJA1 turnover and mitochondrial polarity,Biochemical and Biophysical Research Communications.

  5. Arora A, Godse S, Pal M, Misra A, Sepuri RT, Mallikarjun NT, Gujela A, Patel S, Sharma A, Menon S, Bakshi G, Prakash G (2025). Real-world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non-muscle invasive bladder cancer-Implications for global shortage. BJUI Compass.6 (6):e70034. PMID: 40497260

  6. Arum B, Gopinath P, Jha A, Tripathi N, Dastager S, Hasan SK (2025). Nigericin-induced apoptosis in acute myeloid leukemia via mitochondrial dysfunction and oxidative stress. Oncology Research.

  7. Bjelic- Radisic V, Cardoso F, Weis J....Nookala M...Duhoux F...etal. on behalf of the EORTC Quality of Life Group and Breast Cancer Group (2025). An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42. The Breast. PMID: 39947087

  8. Bhosale S, Golani A, Joshi M, Kulkarni A (2025). Perioperative euglycemic DKA: The YIN and YANG of sodium-glucose cotransporter 2 inhibitors. Journal of Anaesthesiology Clinical Pharmacology 41(1): 193-195.

  9. Bajpai J, Sarkar L, Rath S, Chandrasekharan A, Panda G, Jakar D, Pawar A, Ghosh J, Laskar S, Rekhi B, Khanna N, Manjali JJ, Ramadwar M, Purandare N, Bhargava P, Chakrabarty N, Gala K, Kembhavi Y, Rangarajan V, Banavali S, Gupta S (2025). Ten-year follow-up of outcomes, patterns of care, and psychosocial burden in adolescent and young adult (AYA) patients with bone sarcomas from a large cohort in a low-income and middle-income country (LMIC). Cancer. 131(1): e35547. PMID: 39297373

  10. Behel V, Hait S, Noronha V, Chowdhury A, Chandrani P, Patil V, Menon N, Mishra R, Bawaskar B, Dahimbekar G, Shah M, Kaushal R, Veldore V, Goswami H, Bharde A, Khandare J, Shafi G, Choughule A, Tyagi N, Desai S, Prabhash K, Dutt A (2025). Assessment of plasma derived microbiome profiles in lung cancer using targeted and whole exome sequencing. NPJ Systems Biology and Applications. 11(1):62. PMID: 40483308

  11. Banerjee R, Mohan M, Rejeski K, Puliafito B,Cirstea D, Kaur G, Midha S, McCaughan G, Kumar N, Mehra N, Bagal B, Raje N (2025). IVIG prophylaxis should be initiated following bispecific antibody therapy in multiple myeloma regardless of IgG levels. Blood Advances.

  12. Bajpai J, Sarkar L, Rath S, Pawar A, Chandrashekharan A, Panda G, Jakar D, Ghosh J, Laskar S, Rekhi B, Khanna N, Jose J, Ramdawar M, Purandare N, Bhargava P, Chakrabarty N, Gala K, Kembhavi Y, Rangarajan V, Banavali S, Gupta S (2025). Prognostic modeling for bone sarcomas based on a large prospective cohort from a tertiary care cancer center in India. JCO Global Oncology.

  13. Bal M, Nath PS, Janu A, Thiagarajan S, Pantavaidya G (2025). First report of SMARCA4-deficient carcinoma ex-pleomorphic adenoma in salivary glands. Histopathology. 86(3):480-482. PMID: 39502002

  14. Bhat M, Saha P, Narasimhan M, Shelar A, Hole A, CM Krishna, Govekar R (2025). Analysis of lipids by Raman spectroscopy and mass spectrometry provides a detection tool and mechanistic insight into imatinib resistance in CML-BC. Biochimica et Biophysica Acta (BBA) - General Subjects.

  15. Chaudhary N, Choudhary BS, Shivashankar A, Manna S, Ved K, Shaikh S, Khanna S, Baar J, Dani J, Sahoo S, Soundharya R, Jolly MK, Verma N. EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI. Cancer Cell International. 25(1):55. PMID: 39972345.

  16. Chilukuri S, Sayan M, Pra A, Murthy V (2025). Elective regional nodal Irradiation in prostate cancer. Seminars in Radiation Oncology. 35(3): 374-384.PMID: 40516972

  17. Cepeda S, Esteban-Sinovas O, Romero R, Singh V, Shett P, Moiyadi A, Zemmoura I, Giammalva GR, Del Bene M, Barbotti A, DiMeco F, West TR, Nahed BV, Arrese I, Hornero R, Sarabia R (2025). Real-time brain tumor detection in intraoperative ultrasound: From model training to deployment in the operating room. Computers in Biology and Medicine. 193:110481. PMID: 40449046

  18. Cepeda S, Esteban-Sinovas O, Singh V, Moiyadi A, Zemmoura I, Del Bene M, Barbotti A, DiMeco F, West TR, Nahed BV, Giammalva GR, Arrese I, Sarabia R. Prognostic modeling of overall survival in glioblastoma using radiomic features derived from intraoperative ultrasound: A multi-institutional study. Cancers. 17(2):280. PMID: 39858063.

  19. Chakrabarti D, Albertsen P, Adkins A, Kishan A, Murthy V, Parker C, Pathmanathan A, Reid A, Sartor O, Van As N, Walz J, Tree A(2025). The contemporary management of prostate cancer. CA: A Cancer Journal for Clinicians

  20. Chakrabarty N, Bhalla AS, Jana M, Mahajan A (2025).Imaging Spectrum of Mesenchymal Tumors of Lungs and Pleura. Journal of Thoracic Imaging. PMID: 40452270

  21. Chopra S, Bosse T, Horeweg N, Deodhar K, Menon S, Rafael T, Pai V, Rijstenberg L, Kemenade F, Kannan S, Mahantshetty U, Segedin B, Huang F, Bruheim K, Perez M, Rai B, Tan L, Giannakopoulus N, Schmid M, Tanderup K, Pötter R, Nout R (2025). Biomarker expression and impact on clinical outcomes in an international study of chemoradiation and MRI-based image-guided brachytherapy for locally advanced cervical cancer: BIOEMBRACE. International Journal of Radiation Oncology, Biology, Physics. 127(1): 97-106.PMID: 39067486

  22. Cepeda S, Esteban-Sinovas O, Singh V, Shetty P, Moiyadi A, Dixon L, Weld A, Anichini G, Giannarou S, Camp S, Zemmoura I, Giammalva GR, Del Bene M, Barbotti A, DiMeco F, West TR, Nahed BV, Romero R, Arrese I, Hornero R, Sarabia R. Deep learning-based glioma segmentation of 2D intraoperative ultrasound images: A multicenter study using the Brain Tumor Intraoperative Ultrasound Database (BraTioUS). Cancers. 17(2):315. PMID: 39858097.

  23. Chatterjee G, He R, Patkar N, Viswanatha D, Langerak AW. Molecular techniques in haematopathology: what and how? Histopathology. 86(1):38-57. PMID: 39403025

  24. Chilukuri S, Sayan M, Pra A, Murthy V (2025). Elective regional nodal Irradiation in prostate cancer. Seminars in Radiation Oncology. 35(3): 374-384.PMID: 40516972

  25. Chaudhary N, La Ferlita A, Choudhary BS, Jog E, Kazi M, Yahya S, Dalwai A, Ostwal V, Kumar S, Redkar S, Khapare N, Kailaje V, B A, Gera P, Bal M, Verma N, Thorat R, Saklani A, Sehgal L, Dalal SN (2025). Patient-derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas. Clinical Cancer Research. PMID: 39879477

  26. Choudhary B, Chaudhary N, Khan B, Vijan A, Mandal D, Pilankar L, Gawand S, Uttankar P, Sharma M, Shivashankar A, Doloi R, Joshi N, Das M, Dalal SN (2025). LCN2 promotes focal adhesion formation and invasion by stimulating Src activation. Journal of Cell Science. 138(11):jcs263663. PMID: 40356520

  27. Chen X, Patkar N, Tembhare P, Papagudi S,Yeung C, Kanagal Shamanna R, Gujral S, Wood B,Naresh KN (2025). Fifth edition WHO classification: myeloid neoplasms. Journal of Clinical Pathology

  28. Cortes J, Kim D-W, Saikia T, Khattry N, Rathnam K, Alvarado Y, Hannah G, Tantravahi S, Apperley J, Charbonnier A, García-Gutiérrez V, Lucchesi A, Dima D, Illés Á, Popav V, Abruzzese E, Nag A, Apte S, Badar T, Yao S-L, Saxena U, Sreenivasan J, Inamdar S, Chimote G, Nicolini F (2025). Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial. Lancet Haematology.

  29. Dahara R, Bhattacharyya D (2025). Intra-Golgi Golgin PpSgm1 and GRIP domain Golgin PpImh1 synergistically mediate Golgi cisternal stacking. Journal of Cell Science.

  30. Dholam KP, Somani P, Gurav S, Dugad J, Kharade P, Rane PP, Singh GP (2025). Longitudinal assessment of trismus in patients with advanced stage oral and oropharyngeal cancer. Journal of Prosthetic Dentistry.

  31. Dinesan A, Singh M, Mehta P, Maitre P, Murthy V (2025). Acute enteritis with pelvic SBRT: Influence of bowel delineation methods. Clinical and Translational Radiation Oncology.

  32. Dalal N, Dhandapani H, Ingle A, Sharma D,Tayalia P. Functionalized Poly(ethylene Glycol) diacrylate scaffolds for In Situ immunomodulation of dendritic cells targeting melanoma tumor. ACS Biomaterials Science & Engineering

  33. Dasgupta A, Mani S, Chatterjee A, Kannan S, Moiyadi A, Shetty P, Singh V, Menon N, Sahu A, Choudhary A, Bhattacharya K, Puranik A, Dev I, Epari S, Sahay A, Shah A, Bano N, Shaikh F, Gupta T (2025). Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trial. BMC Cancer. 25(1):911. PMID: 40399827

  34. Dev I, Puranik A, Trikalinos N, Girod B, Kim H, Prasad V (2025). Theranostics in lung neuroendocrine tumors. Seminars in Nuclear Medicine. PMID: 40055049

  35. Dwivedi P, Barage S, Jha AK, Choudhury S, Rangarajan V (2025). Robustness of 18F-FDG PET radiomic features in lung cancer: Impact of advanced reconstruction algorithm. Journal of Nuclear Medicine Technology.

  36. Gore S, Mhamane S, Jadhav S, Padvi N, Mhatre A,Joshi P, Sawakare S, Samant V, Chaturvedi P,Pramesh CS, Gupta S, Budukh A. Implementation challenges of government-funded health schemes for cancer treatment at Tata Memorial Centre. Journal of Cancer Policy. 43:100564.

  37. Gaikwad P, Bargir UA, Jodhawat N, Dalvi A, Shinde S, Tamhankar P, Setia P, Kambli P, Dhawale A, Temkar L, Vedpathak D, Jose A, Gupta M, Yadav-Malik R, Dutta S, Bose K, Taur P, Gowri V, Iyengar V, Chougule A, Desai M, Sivasankaran M, Bhattad S, Balaji S, Mudaliar S, Kacha A, Subramanian G, Patel S, Sharma S, Sampagar A, Madkaikar M. Mutational Landscape of Patients with Wiskott Aldrich Syndrome: Update from India. Journal of Clinical Immunology. 45(1):56. PMID: 39688652

  38. George GS, Singh A, Moirangthem R, Patil A, Pullat GB, Sagare S, Krishnatreya M, Mishra A, Sonwane R, Hosseini B, Chaturvedi A, Chaturvedi P, Dikshit R, Mhatre S. Association of decayed, missing, filled teeth score with the risk for buccal mucosa cancer, stratified on tobacco and alcohol use: A multicenter case-control study From India. JCO Global Oncology. 11:e2500119

  39. Gokarn A, Reddy L, Hiregoudar S, Poojary M, Parab S, Punatar S, Chichra A, Mirgh S, Jindal N, Nayak L, Garg K, Saho S, Ojha S, Tembhare P, Rajpal S, Chatterjee G, Patkar N, Kannan S, Pawar A, Bagal B, Subramanian PG, Khattry N (2025). A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilization. Cytotherapy.

  40. Guévelou JL, Sargos P, Ost P, Alongi F, Arcangeli S, Berlin A, Blanchard P, Bruynzeel A, Chapet O, Dal Pra A, Dess RT, Guckenberger M, Loblaw A, Kishan AU, Jereczek-Fossa B, Pasquier D, Shelan M, Siva S, Tree AC, Zamboglou C, Supiot S, Murthy V, Zilli T (2025). Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey. Clinical and Translational Radiation Oncology. 51:100907. PMID: 39845565

  41. Ghosh A, Chaubal R, Das C, Parab P, Das S, Maitra A, Majumder PP, Gupta S, Biswas NK (2025). Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours. Communications Biology. 8(1):207.

  42. Gupta SK, Yadav S, Sharma D, Sandur SK, Khattry N, Goda JS, Gota V(2025). Effect of the radioprotector chlorophyllin on graft versus leukemia response in experimental allogeneic hematopoietic stem cell transplantation. Journal of Ayurveda and Integrative Medicine. 16(2):101109

  43. Gandhi AK, Chopra S, Rastogi M, Mallick I, Cruz MC, Yasuda K, Sum YY, Nagata Y, Wu HG, Prajogi GB, Kodrat H, Ma M, Nisar A, Chitapanarux I (2025). Multicentric Cross-Sectional Survey to Assess the Variation of Fractionation Strategies Used in the Management of Head and Neck Cancers in the Asian Region (INNOCENCE-ASIA). JCO Global Oncology.PMID: 39819125

  44. Ghosh K, Iyer R, Sood S, Islam MS, Labad J, Khadilkar R (2025). Genetic perturbation of cellular homeostasis regulates integrated stress Response signalling to control Drosophila hematopoiesis. Biology Open.PMID: 40362482

  45. Goyal P, Kumar M, Kiran M, Srivastava S, Roy S, Garg S, Salunke S, Lader S, Quadir K, Ansari A, Fatima Z, Qayyumi B, Tuljapulkar V, Chaturvedi P (2025). Optimizing Surgical Margins in Oral Cancer without Frozen Section: A single center retrospective study. European Journal of Surgical Oncology. 51(1): 109360. PMID: 39571517

  46. Ghosh S, Wadasadawala T, Mohanty S, Sarin R, Parmar V, Gupta S (2025). Temporal evolution in patient-reported outcomes in Indian women with breast cancer: A longitudinal Study. JCO Global Oncology. PMID: 40249892

  47. Ghosh-Laskar S, Kumar A, Salunke R, Agarwal JP, Upasani M, Sinha S, Mohanty S, Roy Chowdhury O, Johnny C, Budrukkar A, Swain M, Chaukar D, Pai P, Chaturvedi P, Pantvaidya G, Nair S, Nair D, Deshmukh A, Thiagarajan S, Vaish R, Tuljapurkar V, Joshi P, Shetty R, Singh A, Prabhash K, Noronha V, Joshi A, Menon N, Khan F (2025). Patient selection and outcomes in reirradiation for head and neck cancers: A prospective cohort study. Clinical Oncology.40:103772. PMID: 39955966

  48. Gogoi MP, Das P, Das N, Das S, Narula G, Trehan A, Bakhshi S, Radhakrishnan V, Seth R, Tembhare P, Singh Sachdeva MU, Chopra A, Sundersingh S, Parihar M, Bhattacharya R, Banavali S, Saha V, Krishnan S (2025). Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India.Lancet Regional Health - Southeast Asia 37:100593. PMID: 40487914

  49. Ghosh -Laskar S, Sood S, Chatterjeec A, Sinha S, Sharma S, Chaukar D, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Swain M, Kumar A, Mohanty S, Chaturvedi P, Pai P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Tuljapurkar V, Deshpande M, Joshi A, Noronha V, Prabhash K, D'cruz A. (2025) Presentation and outcomes of second primary malignancies (SPMs) in locally advanced oral cavity squamous carcinoma (LA-OSCC): Secondary analysis of a phase III randomised control trial (NCT00193843). Radiotherapy and Oncology. 29:110944. PMID: 40409369

  50. Hait S, Noronha V, Chowdhury A, Chaudhary A, Bawaskar B, Dahimbekar G, Ahmad S, Joshi A, Patil V, Menon N, Shah M, Kaushal R, Choughule A, Bharde A, Khandare J, Shafi G, Lakhwani D, Desai S, Chandrani P, Prabhash K, Dutt A (2025). The impact of co-occurring tumor suppressor mutations with mEGFR as early indicators of relapse in lung cancer. ESMO Open, 10(4):104479.

  51. Han JX, Koh MJ, Boussi L, Sorial M, McCabe SM, Peng L, Singh S... Shet T, Epari S, Shetty A, Saha S, Jain H Dr, Sengar M…etal (2025). Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium. Blood Advances.9(3):583-602. PMID: 39481087

  52. Halder A, Jadhav PA, Maitra A, Banerjee A, Hole A,Epari S, Shetty P, Moiyadi A, CM Krishna,Srivastava S (2025). Serum Metabolomics Profiling Coupled with Machine Learning Identifies Potential Diagnostic and Prognostic Candidate Markers in Meningioma Using Raman Spectroscopy, ATR-FTIR, and LC-MS/MS. Journal of Proteome Research

  53. Hasan SK, Jayakumar S, Espina Barroso E, Jha A, Catalano G, Sandur SK, Noguera NI (2025). Molecular targets of oxidative stress: Focus on nuclear factor erythroid 2–related factor 2 function in leukemia and other cancers. Cells. 14(10):713

  54. Jadhav PA, Hole A, Saha P, Pansare K, Ghanwat A, Gera P, Bendale K, Krishna CM, Chaudhari P (2025). Exploratory Raman Spectroscopic Studies of Canine Oral tumour types. Journal of Biophotonics.

  55. Jeeva M, Dasgupta A, Chatterjee A, Sahu A, Sridhar E, Moiyadi A, Chinnaswamy G, Gupta T (2025). Third course of radical intent conformal radiation in patients with primary brain tumors. Clinical Oncology.

  56. Jog E, Jainarayanan AK, Ferlita A, Chakraborty A, Dalwai A, Yahya S, Shivashankar A, Choudhary B, Chandramouli A, Kazi M, Jain D, Khapre N, Akshaya B, Khan B, Gera P, Patil P, Thorat R, Verma N, Sehgal L, Saklani A, Kamat S, Dalal SN, Choudhary N (2025). Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer. Redox Biology.79:103458.

  57. Joshi P, Bane S, Chaturvedi P, Gera P, Waghmare SK (2025). Establishment and characterization of patient-derived tongue squamous cell carcinoma cell lines. Human Cell. 38(4):102.

  58. Jaiswal MA, Karn A, Das A, Kumari A, Tiwari S, Dalal SN (2025). 14-3-3ɛ inhibits premature centriole disengagement by inhibiting the activity of Plk1 and Separase. Journal of Cell Science. PMID: 40576425

  59. Joshi P, Kole L, Patil A, Singh A, Shetty R, Nair S, Chaturvedi P (2025). A retrospective study of lip carcinoma at a tertiary cancer centre. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.

  60. Jindal N, Patel K, Garg M, Mirgh S, Chichra A, Nayak L, Gokarn A, Punatar S, Bagal B, Mathew LJ, D'Silva S, Singh M, Khattry N (2025). High risk of graft rejection in patients with HLA homozygosity fFollowing haploidentical transplant using post-transplant xyclophosphamide. Blood Cell Therapy. 8(1):167–9. PMID: 40061176

  61. Katawale S, Tank S, Dhaygude H, Holm R, Shah S, Shinde U, Shidhaye S, Joshi G, Warawdekar U, Nagarsenker M (2025). Systemic delivery of Sorafenib Tosylate loaded LeciPlex®: A comparative assessment of nano assembly, biocompatibility, and in vivo drug disposition. Journal of Drug Delivery Science and Technology

  62. Keith B, Welch DR, Agarwal N, Blair C, Chukwudozie IB, Shevde LA, Boise LH, Burnstein KL, Antalis TM, O'Connor KL, Dalal SN, Ellis S, Nakshatri H. Challenges and opportunities in training cancer researchers. Nature Cancer. PMID: 39747649

  63. Keshari R, Bagale R, Rath S, De A, Banerjee R, Sen S, Srivastava R (2025). Transcutaneous delivery of disease-specific PI3K/Akt/mTOR inhibitor-based hybrid nanoparticles in hydrogel system for the management of psoriasis: Insights from in vivo studies. International Journal of Pharmaceutics.672:125325. PMID: 39954975

  64. Khanna D, Mishra A, Birur P, Shruti T, Gurushanth K, Mukhia N, Pathak R, Gurmeet Singh A, Shetty A, Pradhan S, Chaturvedi P. A prospective study on diagnostic accuracy of technology-enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India. Cancer. 131(1): e35702. PMID: 39748663

  65. Khanvilkar S, Mittra I (2025). Copper imparts a new therapeutic property to resveratrol by generating ROS to deactivate cell-free chromatin. Pharmaceuticals. 18(1):132. PMID: 39861193.

  66. Kumar B, Mittal P, Gupta A, Mulani J, Bhajbhuje R, Kannan S, Jain J, Chopra S (2025). Learning curve and proficiency assessment for gynecological brachytherapy amongst radiation oncology trainees in India: Results from a prospective study. Brachytherapy.

  67. Krishnan A, Maitre P, Kashid S, Pansande N, Singh M, Singh P, Dubey S, Phurailatpam R, Patil D, Joshi A, Misra A, Arora A, Pal M, Prakash G, Murthy V (2025). Online adaptive radiotherapy for bladder preservation: Transitioning to hypofractionation. International Journal of Radiation Oncology,Biology,Physics. 122(4):995-1001. PMID: 40127844

  68. Kizhakethil RV, Varma AK, Barage SH, Ramesh Kumar N, Nagarajan K, Santhosh Kumar AW, Kamble SS (2025). Repercussions of the calpain cleavage-related missense mutations in the cytosolic domains of human integrin-β subunits on the calpain–integrin signaling axis. International Journal of Molecular Sciences. 26(9):4246. PMID: 40362482

  69. Kumar S, Dey P, Pathak AK, Wadawale A, Maurya DK, Natu K, Bose K, Goswami D (2025). Structure-activity relationship of ciprofloxacin towards S-Spike Protein of SARS-CoV-2: Synthesis and In-silico evaluation. Journal of Chemical Information and Modeling. 65(2):825-844. PMID: 39800972

  70. Kumar S, Joshi A, Takke A, Varghese D, Pathak S, Noronha V, Kumar P, Gota V (2025). Comparison of PSA response to generic versus innovator (Zytiga) formulations of abiraterone in metastatic CRPC: A retrospective analysis. Indian Journal of Medical and Paediatric Oncology.

  71. Laskar SG, Mohanty S, Sinha S, Kumar A, Pantvaidya G, Thiagarajan S, Budrukkar A, Swain M, Deshmukh A, Nair D, Vaish R, Tuljapurkar V, Dravid C, Nair S, Joshi P, Shetty R, Singh AG, Chaturvedi P (2025). Adjuvant external beam radiotherapy in differentiated thyroid cancers: An audit of clinical practice, adapting to new evidence. Head Neck.

  72. Laskar SG, Sinha S, Jeeva M, Gupta M, Karmakar S, Kumar A, Mohanty S, Mahajan P, Timmanpyati S, Balaji A, Budrukkar A, Swain M, Khan F, Pantvaidya G, Deshmukh A, Nair D, Chaukar D, Pai P, Thiagarajan S, Vaish R, Tuljapurkar V, Chaturvedi P (2025). Prophylactic Versus Reactive (PvR) feeding in patients undergoing (Chemo)radiation in head and neck cancers: Results of a phase III randomized controlled trial. Head Neck.

  73. Le Guévelou J, Mathieu R, Peyrottes A, Dariane C, Murthy V, Nicosia L, Jacquet-Kammerer SF, Zilli T, Peyronnet B, Chargari C, Anract J, Sargos P, Supiot S (2025). Tailoring prostate cancer external beam radiotherapy for patients with lower urinary tract symptoms. World Journal of Urology. 43(1):361. PMID: 40481864

  74. Lester-Coll N, Pra A, Murthy V, Kamran S (2025). Advancements in prostate cancer radiotherapy: The role of PSMA PET imaging, Practical Radiation Oncology.

  75. Lonare A, Raychaudhuri K, Shah S, Madhu G, Sachdeva A, Basu S, Thorat R, Gupta S, Dalal SN (2025). 14-3-3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer. International Journal of Cancer.156(3):623-637.PMID: 39239852

  76. M Serban, Spampinato S, de Leeuw A, Fortin I, Kirisits C, Ye XY, Schmid M, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Bhavana R, Cooper R, Steen Banasik E V, Limbergen EV, Pieters BR, Tan LT, Chopra S, Nout R, Nesvascil N, Kirchheiner K, Pötter R, Jürgenliemk-Schulz IM, Tanderup K (2025). Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis. Radiotherapy Oncology.PMID: 40449684

  77. Mallick I, Murthy V (2025). Making ARTwork in low-resource settings. International Journal of Radiation Oncology,Biology,Physics. 122(3): 542-544. PMID: 40484464

  78. Mahajan A, Panzade G, Bhuniya T, Das P, Bhattacharjee B, Das S, Chowdhury A, Chakraborty K, Guha S, Samant A, Dey A, Ghosh S (2025). Revolutionizing lung cancer treatment: Introducing PROTAC therapy as a novel paradigm in targeted therapeutics. Current Problems in Cancer. 54:101172. PMID: 39731828.

  79. Manjali J, Gupta T, Vinod S, Agarwal JP (2025). Bridging gaps in cancer care with quality indicators in radiotherapy. Clinical Oncology. 41:103831. PMID: 40221361

  80. Masuku S, Mandrik O, Mdege N, Mishra G, Muwonge R, Meyer-Rath G, Lince-Deroche N, Brennan A (2025). Breast cancer screening using clinical breast examination: A cost-effectiveness analysis for South Africa. Value in Health Regional Issues. 49: 101127.

  81. Maitre P, Zaorsky N, Dess R, Koontz B, Tree A, Zilli T (2025). Precision over tradition: Transforming prostate cancer treatment with stereotactic radiation therapy. International Journal of Radiation Oncology,Biology Physics. 121(5): 1093-1097.

  82. Mehta D, Paradkar A, Nayak P, Rekhi B, Mohanty B, Chaudhari P, Waghmare SK (2025). Establishment and molecular characterization of the novel cutaneous squamous cell carcinoma cell line from advanced-stage Indian patient. Human Cell.38 (4):108. PMID: 40413685

  83. Menon SR, Sahu S, Mitra A, Chakraborty A, Malhotra G, Kamaldeep, Tawate M, Lad S, Rakshit S, Upadhye T, Ray MK, Banerjee S (2025). On the automated radiosynthesis of pharmaceutical grade [68Ga]Ga-Pentixafor, its pre-clinical evaluation, clinical application and radiation dosimetry aspects. Scientific Reports. 15(1):6476. PMID: 39987209

  84. Mirgh S, Yanamandra U, Vishvanathan G, Gundeti S, Khattry N, John M, Malhotra P, Menon H, Das B, Nair R, Nair V, Saikia T, Kumar S (2025). Clinical perspectives on amyloidosis in India: A systematic literature review. Clinical Lymphoma Myeloma and Leukemia. PMID: 40537367

  85. Mirgh S, Bagal B, Punatar S, Gokarn A, Jindal N, Chichra A, Nayak L, Hiregoudar S, Poojary M, Saha S, Parab S, Ojha S, Tembhare P, Patkar N, Rajpal S, Chatterjee G, Mathew L, Subramanian P, Khattry N (2025). Moving byond G-CSF mobilization-learning from a 15-Year experience of different stem cell mobilization regimens in multiple myeloma. Cancer Medicine. 14(14):e71068.

  86. Mahaddalkar T, Banerjee A, Ketkar M, Thorat R, Gardi N, Dutt S (2025). Aurora Kinase A and B inhibition abrogates 'Neosis', a non-mitotic cell division of GBM residual cells and prevents GBM recurrence. Oncogene.

  87. More A, Parikh P, Kamtalwar S, Pagdhune A (2025). A case series of Pseudohyperkalemia: A diagnostic dilemma in cancer patients with reactive thrombocytosis. Cureus. 17(4):e81851.

  88. Mukhare R, Gandhi KA, Kadam A, Raja A, Singh A, Madhav M, Chaubal R, Pandey S, Gupta S (2025). Integration of organoids with CRISPR screens: A narrative review. Biology of the Cell. 117(4):e70006

  89. Mirgh S, Lall S, Punatar S, Gokarn A, Jindal N, Chichra A, Bhat V, Khattry N (2025). Dirt Under the finger-nails-more malignant than malignancy. American Journal of Hematology.

  90. Mirikar D, Banerjee N, Prabhash K, Kaushal RK, Naronha V, Pramesh CS, Karimundackal G, Joshi A, Rane S, Basak R (2025). Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR. Scientific Reports. 15(1):1252. PMID: 39775010

  91. Murthy V, Marvaso G, Jereczek-Fossa BA, Thoma SA, Vogel M, Schmidt-Hegemann NS, Shelan M, Siva S, Hoelscher T, Kishan AU, Peeken JC, Gillessen S, Guckenberger M, Herrmann K, Fendler WP, Zilli T, Spohn SKB, Zamboglou C (2025). The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care. European Urology. PMID: 39837736.

  92. Munne K, Patil P, Mayekar A, Birje S, Bhekare G, Prabhu Valawalkar S, Akula A, Tryambake V, Kamat S, Dalvi R, Tandon D, Surve S, Begum S, Shikhare M, Pimple S, Patil A (2025). Determinants of cervical cancer screening acceptance among women in urban and tribal communities of Maharashtra, India: a cross-sectional study. Cancer Prevention Research. PMID: 40509937

  93. Murthy V, Mallick I, Maitre P, Mulye G, Arunsingh M, Valle L, Steinberg M, Kennedy T, Loblaw A, Kishan AU (2025). Pelvic Regional Control With 25 Gy in 5 Fractions in Stereotactic Radiation Therapy for High-Risk Prostate Cancer: Pooled Prospective Outcomes From the SHARP Consortium. International Journal of Radiation Oncology Biology Physics. 122(1):93-98. PMID: 39755216

  94. Murthy V, Samanta A, Maitre P, Nayak P, Singh P, Agrawal A, Joshi A, Prakash G (2025). Abiraterone for "STAMPEDE-Like" cohort of high-risk prostate cancer in the PSMA-PET era: too much, too early? Prostate Cancer and Prostatic Diseases. PMID: 40404801

  95. Maity A, Sathyanarayanan A, Kumar R, Vora J, Gawde J, Jain H, Bagal B, Subramanian PG, Sengar M MD, DM, Khattry N, Patkar N, Hasan SK (2025). RAPID-CRISPR: Highly sensitive diagnostic assay for detection of PML-RARA isoforms in acute promyelocytic leukemia. Blood Advances. 9(3):463-47. PMID: 39622167

  96. Mishra GA, Pimple SA, Anand KV, Kulkarni VY, Patil AS, Biswas SK (2024). Acceptability and validity of HPV self-sampling for cervical cancer screening among women living in different ecological settings in India. International Journal of Cancer. 156(6):1142-1153. PMID: 39412108

  97. Mahajan A, Agarwal U, Ashtekar RM, Chakrabarty N,Vaish R, Patil VM, Noronha V, Menon N, Smriti V,Agarwal JP,Ghosh-Laskar S, D'Cruz AK, Chaturvedi P, Pai P, Patil A, Bal M, Rane S, Mittal N, Prabhash K (2025). Compartmentalization of high infratemporal Fossa in oral cavity squamous cell carcinomas and its impact on clinical outcome. Current Oncology.

  98. Murthy V, Dal Pra A (2025). Transporting testosterone home: Navigating the Road to Recovery. European Urology. 87(1): 58-59. PMID: 39472203.

  99. Mojidra R, Gardi N, Bagal B, Khattry N, Gokarn A, Punatar S, Govekar R (2025). Genomic analysis identifies an incipient signature to forecast imatinib resistance before start of treatment in patients with chronic myeloid leukemia. Advances in Biomarker Sciences and Technology

  100. Noronha V, Choudhary J, Ramaswamy A, Pillai A, Rao AR, Kumar A, Dhekale R, Mahajan S, Daptardar A, Sonkusare L, Vagal M, Mahajan P, Timmanpyati S, Gota V, Shetake AG, Pawar A, Prabhash K (2025). Treatment goals, desire for disclosure, and perception of cancer treatment outcomes in older patients with cancer: An observational study from a tertiary care center in India. Journal of Geriatric Oncology. 16(3):102198. PMID: 39955889

  101. Noronha V, Menon N, Patil VM, Shah M, Joshi A, Shah S, Nawale K, Surve R, Bafna G, Jogdhankar S, Shelar P, Shetake A, Singh A, Salian S, Jadhav P, Shah H, Mer N, Vohra A, Majumdar S, Banavali S, Badwe R, Prabhash K (2025). Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial. British Journal of Cancer. 132(1):58-68. PMID: 39592738.

  102. Oak S, Karajgikar O, Gadewal N, Sulkshane P, Verma T, Gupta S, Teni T (2025). The deubiquitinase inhibitor WP1130 drives nuclear aggregation and reactivation of mutant p53 for selective cancer cell targeting. FEBS Journal.

  103. Pachuau L, Lalremmawia H, Ralte L, Vanlalpeka J, Pautu JL, Chenkual S, Zomuana T, Lalruatfela ST, Zohmingthanga J, Chhakchhuak L, Varma AK, Kumar NS (2025). Uncovering novel pathogenic variants and pathway mutations in triple-negative breast cancer among the endogamous mizo tribe. Breast Cancer Research and Treatment. 209(2):375-387. PMID: 39384723

  104. Piñeros M, Vignat J, Colombet M, Laversanne M, Ferreccio C, Heise K, Mhatre S, Koshiol J, Bray F (2024). Global variations in gallbladder cancer incidence: What do recorded data and national estimates tell us? International Journal of Cancer. 156(7):1358-1368. PMID: 39580808.

  105. Puranik AD, Dev ID, Prasad V (2025). Frontiers in radiopharmaceuticals for neuroendocrine tumors. Journal of Neuroendocrinology.

  106. Punatar S, Kumbhalwar K, Kalantri SA, Gokarn A, Nayak L, Chichra A, Mirgh S, Jindal N, Mathew L, Kannan S, Khattry N (2025). Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemias. Blood Cell Therapy. 8(2):210-216.PMID: 40486077

  107. Pandit R, Yami Channaiah C, Lila AR, Karlekar M, Sarathi V, Memon SS, Barnabas R, Gupta T, Shah N, Bandgar T (2025). Long-term outcomes of pituitary radiotherapy and their predictive factors in childhood and adolescent-onset cushing disease. European Journal of Endocrinology.

  108. Purohit S, Mandal G, Biswas S, Dalui S, Gupta A, Roy Chowdhury S, Bhattacharyya A (2025). AXL/GAS6 signaling governs differentiation of tumor-associated macrophages in breast cancer. Experimental Cell Research.441 (1): 114324. PMID: 39510154

  109. Rajput N (2025). Menopause: A midlife crisis for women in India. BMJ Global Health. 10:e017863.

  110. Rai P, Mahajan K, Janu AK (2025). Dedifferentiated chondrosarcoma with multiple synchronous osteosarcomas in a young female patient. Radiology: Imaging Cancer. 7(3):e240522.

  111. Ramani N, Patwardhan RS, Checker R, Singh B, Morjaria S, Kumar BK, Gurjar M, Gota V, Sharma D (2025). Preclinical evaluation of sodium copper chlorophyllin: safety, pharmacokinetics, and therapeutic potential in breast cancer chemotherapy and cyclophosphamide-induced bladder toxicity. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID: 40274623

  112. Ramaswamy A, Bhargava P, Gota V, Srinivas S, Sultana N, Mandavkar S, Jadhav P, Gandhi K, Mer N, Khan N, Vora M, Gujarathi H, Bhandare M, Chaudhari V, Shrikhande SV, Ostwal V (2025). Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: A randomized clinical trial (AFPAC Study). Cancer. 131(13):e35945. PMID: 40542713

  113. Ranade M, Epari S, Gurav M, Sahay A, Shetty P, Prasad M, Gupta T, Chinnaswamy G (2025). Lymphoid enhancer-binding factor 1 (LEF1): a reliable immunohistochemical predictive marker for WNT-activated medulloblastoma. Childs Nervous System. 41(1):213. PMID: 40528003

  114. Raj J, Shah J, Ghanekar S, John G, Goda JS, Chatterjee A (2025). Pharmacological and therapeutic innovation to mitigate Radiation-Induced Cognitive Decline (RICD) in brain tumor Patients. Cancer Letters.

  115. Rajendra A, Sengar M, Korula A, Ganesan P, Jain H, Divya K, Samuel P, Perumal Kalaiyarasi J, Prakash G, John MJ, Palassery R, Nair CK, Shet T, Selvarajan S, Nayak L, Karunakaran P, Fouzia NA, Prakash O, Bagal B, Mehra N, Kumaran S, Epari S, Thorat J, Radhakrishnan V, Abraham A (2025). Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium. Blood Cancer Journal. 15(1):38.

  116. Rai P, Janu AK, Shetty N, Kulkarni S (2025). Current landscape of Short-T2 imaging techniques in the musculoskeletal system: The past, present and future. Journal of Magnetic Resonance Imaging.

  117. Rahman MM, Rahman MS, Islam MR, Gilmour S, Haruyama R, Budukh A, Shankar A, Mishra G,Mehrotra R, Matsuda T, Inoue M, Abe SK (2025). Regional variations and inequalities in testing for early detection of breast and cervical cancer: Evidence from a nationally representative survey in India. Journal of Epidemiology. 35(3):129-140

  118. Rathi A, Choudhari AK, Chatterjee A, Sahay A, Bhattacharya K, Sahu A, Puranik AD, Shah A, Dasgupta A, Gupta T, Epari S (2025). Spinal Diffuse Midline Glioma H3 K27M-Altered: Report of a Rare Tumor with Extracranial Skeletal Metastases and Review of Literature. International Journal of Surgical Pathology. 33(4):907-915. PMID: 39376094.

  119. Reddy R, Gaiwak V, Goda JS, Teni T (2025). ‘Nelfinavir sensitizes a clinically relevant chemo-radioresistant cervical cancer in-vitro model by targeting the AKT-USP15/USP11-HPV16 E6/E7 axis. Biochemistry and Biophysics Reports. 42:101987. PMID: 40242402

  120. Sundararajan R, Hegde SR, Panda AK, Christie J, Gadewal N, Venkatraman P. Loss of correlated proteasomal subunit expression selectively promotes the 20SHigh state which underlies luminal breast tumorigenicity. Communications Biology. 8(1): 55.

  121. Sandhbor P, John G, Bhat S, Goda JS (2025). Immune response recalibration using immune therapy and biomimetic nano-therapy against high-grade gliomas and brain metastases. Asian Journal of Pharmaceutical Sciences. 20(2):101021. PMID: 40224727

  122. Sawant P, Saoba S, Kadam P, Gupta D, Ponnada AK, Khanna D, Perera S, Tshomo U, Ervik M, Mery L, Bray F, Budukh A (2025). The Nirmiti application: An innovative tool for extending CanReg5 analyses to cancer mortality and paediatric cancer. International Journal of Cancer. 157(1): 161-169. PMID: 40156432

  123. Salma NS, Vysakh R, Ranjith CP, Anjana PT, Gupta T, Laskar S (2025). Structural Quality Indicators in Radiation Oncology: Insights and Implications. Clinical Oncology. 38:103624. PMID: 39209679

  124. Sawant V, Mithun S, Jha AK, Rangarajan V (2025). Monte carlo simulation of characteristics of discovery NM/CT 670 pro SPECT system for routinely used diagnostic and therapeutic radionuclides. Journal of Nuclear Medicine Technology.

  125. Shaikh N, Pandey M, Manna S, Gawde J, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB (2025). Evaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapy. Oral Oncology. 165: 107346.PMID: 40347575

  126. Saravanan L, Mahale A, Gota V, Khandelia P, Kulkarni OP (2025). Necrostatin-1 attenuates oral squamous cell carcinoma by modulating tumour immune response in mice. Fundamental and Clinical Pharmacology. 39(3):e70008

  127. Shankar MSR, Neeraja M, Chowdhry M, Yadav A, Machiraju S, Singh M, Gowrishanker S (2025). "Virtual crossmatch reveals donor-specific MICA antibodies in antibody mediated rejection: First established Indian case". Transplant Immunology. 90:102229. PMID: 40280498

  128. Shukla A, Kashyap S, Patil S, Varma AK, Ghosh SK, Kondabagil K (2025). The putative packaging ATPase of Acanthamoeba polyphaga mimivirus is an essential protein that interacts with the genome segregation and packaging machinery. FASEB Journal. 9(12):e70685. PMID: 40512099

  129. Singh M, Murthy V, Ost P (2025). Debate 3: Metastasis directed therapy in oligometastatic prostate cancer. 35(3): 423-432. PMID: PMID: 40516977

  130. Solanki SL, Sanapala V, Ambulkar RP, Agarwal V, Saklani AP, Maheshwari A. A Prospective Observational Study on Compliance with Enhanced Recovery Pathways and Their Impact on Postoperative Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Journal of Gastrointestinal Cancer. 56(1):155.

  131. Srinivasan S, Narayan A, Dhamne C, Chichra A, Khemani P, Dhariwal N, Ranjan R, Shah S, Shet T, Gollamudi VRM, Roy Moulik N, Banavali SD, Narula G. Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphoma. British Journal of Haematology. PMID: 40394816.

  132. Saha A, Goswami D, Hole A, Bendale K, Chaudhari P, CM Krishna (2025). Serum Raman spectroscopy explorations in Canine cancers: A pilot study. Journal of Raman Spectroscopy.

  133. Schmid S, Mirchia K, Tietze A, Liu I, Siewert C, Nückles J, Schittenhelm J, Behling F, Snuderl M, Hartmann C, Brandner S, Paine SML, Korshunov A, Hasselblatt M, Coras R, Epari S, Stadelmann C, Zechel S, Simon M, Wilson Y, Gianno F, Calixto-Hope GL Jr, Zherebitskiy V, Kaimaktchiev VB, Robinson L, Aldape K, Hoving EW, Tops BBJ, Perera AA, Göller P, Hernáiz Driever P, Wesseling P, Koch A, Perry A, Sahm F, Jones DTW, Capper D (2025). VGLL-fusions define a new class of intraparenchymal CNS schwannoma. Neuro Oncology. 27(4):1031-1045. PMID: 39713960

  134. Singh AG, Chaturvedi P. (2025) Areca nut and oral cancer. Oral Diseases. 31(5): 1467-1472.PMID: 38566541

  135. Singh AG, Sinha S, Shetty R, Joshi P, Nair SV, Chaturvedi P (2025). Impact of Local Extent of Tumor on the Survival Outcomes for Surgically Treated Tongue Cancers. Head Neck.

  136. Shende R, Dhoble SJ, Gayake U, Saroj D (2025). Monte Carlo modeling and dosimetric validation of GammaMed Plus 192Ir source for HDR brachytherapy application using TOPAS. Applied Radiation and Isotopes. 215:111584. PMID: 39546846

  137. Shabrish S, Naorem LD, Mohanty S, Kumar R, Lopes R, Akhter N, Khare NK, Joshi R, Sawant R, Raghuram GV, Jadhav V, Shinde S, Chandrani P, Mittra I (2025). Induction of cancer stem cells from mouse fibroblasts. Scientific Reports. 15(1): 25489.

  138. Sharma G, Jadhav P, Banerjee S, Gupta D, Anand M, Ganguly K, Srivastava S, CM Krishna (2025). Serum Raman Spectroscopy – An exploratory study for detection of chronic obstructive pulmonary disease. Vibrational Spectroscopy.

  139. Sharma P, Das D, Khanna D, Budukh A, Khokhar A, Pradhan S, Khanna AK, Chaturvedi P, Badwe R (2025). Prevalence and associated factors of mammography uptake among the women aged 45 years and above: policy implications from the longitudinal ageing study in India wave I survey. BMC Public Health. ;25(1):1073. PMID: 40108533.

  140. Shroff K, Shetty P, Singh V, Epari S, Sahay A, Moiyadi A (2025). Clinical value of optimizing extent of resection in adult diffuse gliomas. Clinical Neurology and Neurosurgery. 251:108838.

  141. Singh M, Katdare A, Ghosh S, Choudhury S, Phurailatpam R, Patil D, Tiwari M, Anaz M, Chougle N, Sable N, Agrawal A, Pawar A, Rangarajan V, Maitre P, Murthy V (2025). PSMA-PET guided Intra- prostatic Boost in Prostate SBRT (PROBE): A phase II trial. International Journal of Radiation Oncology,Biology, Physics.

  142. Trivedi V, Kore H, Poojary D, Noronha V, Bal M, Chandrani P, Choughule A, Pange P, Gupta V, Menon N, Patil V, Shah M, Chaturvedi P, Prabhash K, Dutt A. Genomic characterization of papillary thyroid cancer reveals germline mutations associated with congenital hypothyroidism. JCO Global Oncology. 11:e2500043.

  143. Tembhare P, Chen X, Chan JKC, Wood B, Naresh KN (2025). Fifth edition WHO classification: precursor lymphoid neoplasms, acute leukaemias of mixed or ambiguous lineage, myeloid/lymphoid neoplasms, and histiocytic and dendritic cell neoplasms, including strategies for application in resource-limited settings. Journal of Clinical Pathology. PMID: 40318860

  144. Trikha M, Noronha V, Shah M, Patil V, Menon N, Singh A, Chandrani P, Shetty O, Kaushal RK, Pai T, Janu A, Purandare N, Prabhash K (2025). Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with advanced lung cancer in India. Ecancermedicalscience. 19:1867. PMID: 40492223

  145. Trivedi V, Noronha V, Bal M, Chandrani P, Poojary D, Saldanha E, Choughule A, Pange P, Gupta V, Menon N, Patil V, Shah M, Chaturvedi P, Prabhash K, Dutt A. Comprehensive genomic profiling of anaplastic thyroid cancer identifies alterations in THRA, a potential modifier of cellular plasticity. JCO Global Oncology. 11:e2400610.

  146. Wadasadawala T, Syeda N, Kenekar S, Krishnamurthy R, Sarin R, Pathak R, Rane P, Pawar MA, Upadhyay DP, Joshi DS, Parmar V, Nair N, Shejwal M, Chavan S (2025). Cumulative risk of cosmetic worsening following ultra hypo-fractioned whole breast radiotherapy with simultaneous integrated boost: The largest real-world data. Internatonal Journal of Radiation Oncology Biology Physics. PMID: 40449565

  147. Yahya S, Pushpanathan S, Jan S, Chaudhary N, Parray R, Gandhi KA, Thangavel K, Krishnan K, Sudhandiran G (2025). Development and characterization of pegylated Fe3O4-CAPE magnetic nanoparticles for targeted therapy and hyperthermia treatment of colorectal cancer. Scientific Reports 215(1):26008.

Category
International
Select Year
2025
order
7
Back to Top